The fact that everything looks different doesn't mean that all has changed...
Biblio
] . From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders [Internet]. 42nd Congress of the European Society of Lymphology. Mulhouse, France; 2016. http://www.eurolymphology.org/JOURNAL/VOL28-N74-2016/#p=14
Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB)
Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB). Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis. Circulation Research [Internet]. 2016;119(2):210-221. http://circres.ahajournals.org/content/early/2016/05/25/CIRCRESAHA.116.308504 Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis (3.69 MB) Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis: Supplemental Data (3.3 MB)
Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis (3.69 MB) Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis: Supplemental Data (3.3 MB). Lymphatic Vessels in Regenerative Medicine and Tissue Engineering. Tissue Engineering Part B [Internet]. 2016;22(5):1-13. http://online.liebertpub.com/doi/10.1089/ten.TEB.2016.0034 Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB)
Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB). Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Circ Res [Internet]. 2015;116(10):1660-1669. http://circres.ahajournals.org/content/116/10/1660.long
. The genetic causes of primary lymphedema. In: . Erkrankungen des Lymphgefäßsystems. 6th ed. Cologne: Viavital Verlag; 2015. pp. 210-229. Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB)
Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB). Heterogeneity of the origin of the lymphatic system. [German]. Lymphologie in Forschung und Praxis [Internet]. 2015;19(2):84-88. http://www.dglymph.de/fileadmin/global/pdfs/LymphForsch_2-15.pdf Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB)
Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB). Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation [Internet]. 2015;16(4):1160-1172. http://onlinelibrary.wiley.com/doi/10.1111/ajt.13564/abstract
. Lymphangiogenesis in Health and Disease [Internet]. 41st European Societry of Lymphology (ESL) Congress. Lausanne, Switzerland: European Group of Lymphology; 2015. http://www.eurolymphology.org/JOURNAL/VOL26-N72-2015/#p=10 Abstract of the Presentation (Michael Jeltsch) (75.34 KB)
Abstract of the Presentation (Michael Jeltsch) (75.34 KB). Substrate efflux propensity is the key determinant of iPLA-β-mediated glycerophospholipid hydrolysised. Journal of Biological Chemistry [Internet]. 2015;. http://www.jbc.org/content/early/2015/02/23/jbc.M115.642835.abstract J. Biol. Chem.-2015-Batchu-jbc.M115.642835.pdf (786.13 KB)
J. Biol. Chem.-2015-Batchu-jbc.M115.642835.pdf (786.13 KB). The TIE Receptor Family. In: . Receptor Tyrosine Kinases: Family and Subfamilies [Internet]. Springer International Publishing; 2015. pp. 743-775. https://link.springer.com/content/pdf/10.1007%2F978-3-319-11888-8_16.pdf
. CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation [Internet]. 2014;129(19). http://circ.ahajournals.org/content/early/2014/02/19/CIRCULATIONAHA.113.002779.abstract Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB)
Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB). From molecular biology to a causal treatment of lymphatic system disorders [Internet]. 38. Jahreskongress der Deutschen Gesellschaft für Lymphologie e. V. Halle (Saale), Germany: Deutsche Gesellschaft für Lymphologie; 2014. https://jeltsch.org/abstract-Halle2014
. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Sci Signal. 2013;6(282):ra52. Anisimov 2013 Science Signaling (1.92 MB) Anisimov 2013 Science Signaling Supplement (2.09 MB)
Anisimov 2013 Science Signaling (1.92 MB) Anisimov 2013 Science Signaling Supplement (2.09 MB). Die lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseases of the lymphatic system. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(2):96 - 104. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_96.pdf Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB)
Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB). The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Basic principles and embryonic development. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(1):30 - 37. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_30.pdf Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Fundamentals and embryonic development. (2.08 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 1. Grundlagen und Embryonalentwicklung. (1.82 MB)
Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Fundamentals and embryonic development. (2.08 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 1. Grundlagen und Embryonalentwicklung. (1.82 MB). Receptor Tyrosine Kinase-Mediated Angiogenesis. Cold Spring Harbor Perspectives in Biology [Internet]. 2013;5(9). http://cshperspectives.cshlp.org/content/5/9/a009183 Jeltsch et al. (2013): Tyrosine Kinase-Mediated Angiogenesis. CSH Persp Biol (934.46 KB)
Jeltsch et al. (2013): Tyrosine Kinase-Mediated Angiogenesis. CSH Persp Biol (934.46 KB). Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2013;110(32):12960 - 12965. http://www.pnas.org/content/110/32/12960.long
. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development. 2013;140(7):1497-506. Villefranc 2013 (7.86 MB)
Villefranc 2013 (7.86 MB). Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis. Circulation. 2013;127(4):424-434. Anisimov 2013 (6.56 MB) Anisimov 2013 Supplement (4.93 MB)
Anisimov 2013 (6.56 MB) Anisimov 2013 Supplement (4.93 MB). Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181(5):1607-20.
. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood [Internet]. 2011;117(5):1507 - 15. http://view.ncbi.nlm.nih.gov/pubmed/21148085 Veli-Matti Leppänen & Michael Jeltsch et al., Blood 2011 (1.17 MB) Veli-Matti Leppänen & Michael Jeltsch et al. Blood 2011, supplementary data (342.97 KB)
Veli-Matti Leppänen & Michael Jeltsch et al., Blood 2011 (1.17 MB) Veli-Matti Leppänen & Michael Jeltsch et al. Blood 2011, supplementary data (342.97 KB). VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease. Journal of Heart and Lung Transplantation. 2011;30:S118 - S118.
. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev [Internet]. 2010;24(9):875 - 80. http://view.ncbi.nlm.nih.gov/pubmed/20439428 Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB)
Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB). Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell [Internet]. 2010;18(6):630 - 40. http://view.ncbi.nlm.nih.gov/pubmed/21130043 Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB) Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB)
Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB) Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB). Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2010;107(6):2425 - 30. http://view.ncbi.nlm.nih.gov/pubmed/20145116 Veli-Matti Leppänen et al. PNAS 2010 (1 MB) Veli-Matti Leppänen et al. PNAS 2010, supporting information (2.23 MB)
Veli-Matti Leppänen et al. PNAS 2010 (1 MB) Veli-Matti Leppänen et al. PNAS 2010, supporting information (2.23 MB)